Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Treatment helps reduce the risk of liver disease and prevents you from passing the infection to others. In severe cases, antiviral drugs or a hospital stay is needed to prevent complications.Most people diagnosed with chronic hepatitis B infection need treatment for the rest of their lives. This reduces your risk of getting serious liver disease and allows your liver to repair some of the damage so it works better. Search for FDA Guidance Documents "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research. Treatment to prevent hepatitis B infection after exposure If you know you've been exposed to the hepatitis B virus and aren't sure if you've been vaccinated, call your doctor immediately. © 1998-2020 Mayo Foundation for Medical Education and Research (MFMER). Treatment for chronic hepatitis B also requires regular medical evaluations and monitoring to determine if the virus is responding to treatment. It is a major global health problem, and the most serious type of viral hepatitis. Not for implementation. 2016 Jan;63(1):261–83. An injection of immunoglobulin (an antibody) given within 12 hours of exposure to the virus may help protect you from getting sick with hepatitis B. Treatment for chronic hepatitis B may include:Other drugs to treat hepatitis B are being developed.If you've been infected with hepatitis B, take steps to protect others from the virus.If you've been diagnosed with hepatitis B infection, the following suggestions might help you cope:You're likely to start by seeing your family doctor or a general practitioner. For hepatitis B infection, some basic questions to ask your doctor include:Your doctor is likely to ask you a number of questions, including:Mayo Clinic does not endorse companies or products. AGA’s clinical guidelines are evidence-based recommendations to help guide your clinical practice decisions based on rigorous systematic reviews of the medical literature. Unfortunately, this is common in some parts of the world such as in Southeast Asia, China, and sub-Saharan Africa, where as many as 1 in 10 people have chronic hepatitis B … Overview of Cost, Reimbursement, and Cost-Effectiveness Considerations for Hepatitis C Treatment Regimens Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment… AASLD guidelines for treatment of chronic hepatitis B. Hepatology. This project is funded by the Centers for Disease Control and Prevention (CDC). Chronic hepatitis B — Chronic hepatitis B develops more commonly in people who are infected with the virus at an early age (often at birth). The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment.” Risk for chronic infection is related to age at infection: about 90% of infants with hepatitis B go on to develop chronic infection, whereas only 2%–6% of people who get hepatitis B as adults become chronically infected. Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. AGA utilizes the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.